Lista de obras -

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

artículo científico publicado en 2005

A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease

artículo científico publicado en 2020

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

artículo científico publicado en 2017

Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients

artículo científico publicado en 2013

Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group

artículo científico publicado en 2013

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.

artículo científico publicado en 2014

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults ⬇️

artículo científico publicado el 3 de octubre de 2011

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies ⬇️

artículo científico publicado el 26 de mayo de 2010

Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field

artículo científico publicado en 2013

Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche

scientific article published on 17 June 2019

Hematopoietic stem cell transplantation for children with sickle cell disease

artículo científico publicado en 2009

Hematopoietic stem cell transplantation for people with sickle cell disease

artículo científico publicado en 2016

Hematopoietic stem cell transplantation for people with sickle cell disease

artículo científico publicado en 2013

Hematopoietic stem cell transplantation for people with sickle cell disease

artículo científico publicado en 2020

In Regard to Wong et al

artículo científico publicado en 2020

Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation

scientific article published on 31 May 2019

Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population

artículo científico publicado en 2014

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial

artículo científico publicado en 2019

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

artículo científico publicado en 2016

Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Cons

artículo científico publicado en 2017

Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era

artículo científico publicado en 2014

Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children

artículo científico publicado en 2020

Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia

artículo científico publicado en 2018

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia

scientific article published on 16 January 2014

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial

artículo científico publicado en 2014

Lista de obras de

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients

Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults ⬇️

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies ⬇️

Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field

Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche

Hematopoietic stem cell transplantation for children with sickle cell disease

Hematopoietic stem cell transplantation for people with sickle cell disease

Hematopoietic stem cell transplantation for people with sickle cell disease

Hematopoietic stem cell transplantation for people with sickle cell disease

In Regard to Wong et al

Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Cons

Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era

Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children

Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial